Meloxicam clinical trials
Also written N1539 and Mobic.
Counted the way a researcher would: Meloxicam with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Meloxicam is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Meloxicam studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 13 Apr 2000 · MOBIC · NDA 020938 (FDA, Drugs@FDA)
- European Union
- 24 Sept 2020 · Zynrelef · EMEA/H/C/005205 (EMA; in a combination; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
88 studies that test it; most in 2004 (9)
| Year | Studies |
|---|---|
| 1998 | 5 |
| 1999 | 1 |
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 1 |
| 2004 | 9 |
| 2005 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 64 · Other 24
Boehringer Ingelheim (20) · Heron Therapeutics (16) · Baudax Bio (7) · Alkermes, Inc. (3) · InnovaGyn, Inc. (2) · Teva Pharmaceuticals USA (2) · Mylan Pharmaceuticals Inc (2) · Rothman Institute Orthopaedics (2)
Often tested with
Tested in the same studies.
Bupivacaine (18) · Ketorolac (4) · Acetaminophen (3) · Naproxen (3) · Celecoxib (3) · Levonorgestrel (2) · Dexamethasone (2) · Ibuprofen (2)
Related medicines
As reviewed, each with the page that says it.
- One of Anti-Inflammatory Agents, Non-Steroidal source
- One of COX-2 inhibitors source
- One of NSAIDs source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Meloxicam.
- Feb 2027Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive CapsulitisNot applicable · Konya Beyhekim Training and Research Hospital
Studies
Open first, then newest update. How each study uses Meloxicam is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 88
- Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive CapsulitisRecruitingNot applicableKonya Beyhekim Training and Research HospitalNCT07493226Written as oxicam derivatives
- Meloxicam in Mohs Micrographic SurgeryRecruitingPhase 4University of OklahomaNCT07200544Written as Meloxicam 7.5 mg
- Efficacy of Methylprednisolone for Pain Control After ACL RepairRecruitingPhase 4St. Louis UniversityNCT07158476Written as Meloxicam 15 mg
- Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal SurgeryNot yet recruitingPhase 2Beijing Tide Pharmaceutical Co., LtdNCT05950152Written as Meloxicam Injection 30mg
- PK and Safety After C-SectionCompletedPhase 2Heron TherapeuticsNCT03955211Written as HTX-011
- Cohort 2 (Abdominoplasty) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)CompletedPhase 4Heron TherapeuticsNCT06109428Written as HTX-011
- Cohort 1 (TSA) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)CompletedPhase 4Heron TherapeuticsNCT06109415Written as HTX-011
- Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven DaysCompletedPhase 2InnovaGyn, Inc.NCT05695352Written as Meloxicam 15 mg
- HTX-011 for Post-bunionectomy AnalgesiaCompletedPhase 2Heron TherapeuticsNCT02471898Written as HTX-011
- Phase II Study of Ovulation in Obese WomenCompletedPhase 2InnovaGyn, Inc.NCT06306131Written as Meloxicam 15 milligram
- Study of Post-Herniorrhaphy Non-opioid MMA RegimensCompletedPhase 3Heron TherapeuticsNCT03907176Written as HTX-011
- Pediatric Postoperative Analgesia Herniorrhaphy StudyWithdrawnPhase 2Heron TherapeuticsNCT03922048Written as HTX-011
- Pilot Herniorrhaphy Study for Postoperative AnalgesiaCompletedPhase 2Heron TherapeuticsNCT02504580Written as HTX-011
- Phase 2 Herniorrhaphy Study for Opioid EliminationCompletedPhase 2Heron TherapeuticsNCT03695367Written as HTX-011
- Phase 2 Bunionectomy HTX-011 Administration StudyCompletedPhase 2Heron TherapeuticsNCT03718039Written as HTX-011
- Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)CompletedPhase 3Heron TherapeuticsNCT03237481Written as HTX-011
- Bunionectomy Study for Postoperative Analgesia (EPOCH 1)CompletedPhase 3Heron TherapeuticsNCT03295721Written as HTX-011
- Total Knee Arthroplasty Infiltration Study for Postoperative AnalgesiaCompletedPhase 2Heron TherapeuticsNCT03015532Written as HTX-011
- Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) RegimenCompletedPhase 3Heron TherapeuticsNCT03974932Written as HTX-011
- Phase 2B Upper Extremity Nerve Block StudyCompletedPhase 2Heron TherapeuticsNCT03011333Written as HTX-011
See all 88 studies that test Meloxicam →
Given beside what is tested · 5 — Meloxicam is usual care or a partner of the new treatment
- Pre vs Post Block in Total Knee Arthroplasty (TKA)CompletedPhase 4University of MiamiNCT05974501Written as Meloxicam
- Compare Pharmacokinetics and Safety of JP-1366 Between Korean and CaucasianCompletedPhase 1Onconic Therapeutics Inc.NCT05181124Written as coadministration of JP-1366 and meloxicam
- Bawei Shenqi Pill in the Treatment of Ankylosing SpondylitisStatus unknownPhase 2/3Shanghai University of Traditional Chinese MedicineNCT04480359Written as Meloxicam
- Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDsStatus unknownPhase 1Daewoong Pharmaceutical Co. LTD.NCT04490434Written as Meloxicam
- A Comparative Study of Tramadol Hydrochloride Plus Acetaminophen Tablets Maintenance Versus Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Maintenance in Participants With Knee OsteoarthritisCompletedPhase 4Janssen Korea, Ltd., KoreaNCT00635349Written as Meloxicam
As the comparator · 5 — what is tested is compared with Meloxicam
- Safety, Tolerability and Pharmacokinetics of Meloxicam Nanocrystal Injection in Healthy SubjectsCompletedPhase 1Yangtze River Pharmaceutical Group Co., Ltd.NCT06902090Written as Meloxicam Nanocrystal Injection (ANJESO®)
- Efficacy and Safety of Etoricoxib+Diacerein in Osteoarthritis.CompletedPhase 3Laboratorios LiomontNCT07549386Written as Meloxicam 15 mg + diacerein 50 mg
- Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic PainCompletedPhase 3Eurofarma Laboratorios S.A.NCT01147289Written as Meloxicam
- Maximizing Outcomes in Treating Acute MigraineCompletedPhase 3Axsome Therapeutics, Inc.NCT03896009Written as Meloxicam
- Pharmacokinetics and Tolerability of Meloxicam Injected Intramuscularly vs. Tablet in Healthy SubjectsCompletedPhase 1Boehringer IngelheimNCT02183090Written as Meloxicam tablet
What changed recently
From the registry's own updates since Oct 18, 2026.
Results posted3
- Cohort 2 (Abdominoplasty) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)Oct 28, 2026NCT06109428
- PK and Safety After C-SectionOct 27, 2026NCT03955211
- Cohort 1 (TSA) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)Oct 27, 2026NCT06109415
Codes
What other systems call Meloxicam · ClinicalTrials.gg INT006675
- MeSH (NLM) D000077239MeloxicamConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) VG2QF83CGLMELOXICAMConfirmed FDA, NLM, Wikidata
- RxNorm 41493Confirmed FDA, Wikidata
- Wikidata Q414028meloxicamConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61439MeloxicamOne source FDA
- DrugBank DB00814One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077239 | Meloxicam | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | VG2QF83CGL | MELOXICAM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 41493 | — | Confirmed FDA, Wikidata |
| Wikidata | Q414028 | meloxicam | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61439 | Meloxicam | One source FDA |
| DrugBank | DB00814 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.